KPA pressed 26 drug companies for smooth supply of prescription drugs.

Published: 2000-08-10 10:10:00

Updated: 2000-08-10 10:10:00

The KPA urged the MOHW and the KFDA to make a special measure against 26 drug companies for a smooth supply of prescription drugs to the marketplace. The company on subject included 10 foreign invested drug companies such as Arventis, Yuhan Cyanamid, Norvatis Korea, Sanofi Korea, Schering Plough ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK